Similarly, deletion of KEAP1 and PTEN leads to significantly increased NRF2 level in liver cells [85] and contributes to the tumorigenic potent on PTEN-deleted prostate cancer cells [86]. This evidence concerns the gene PTEN and prostate carcinoma.